UBS Asset Management Americas Inc. Has $121.73 Million Stake in Cooper Companies Inc (COO)
UBS Asset Management Americas Inc. increased its stake in Cooper Companies Inc (NYSE:COO) by 12.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 558,683 shares of the medical device company’s stock after purchasing an additional 59,857 shares during the quarter. UBS Asset Management Americas Inc. owned approximately 1.14% of Cooper Companies worth $121,726,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in COO. Advisory Services Network LLC grew its position in Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares in the last quarter. CIBC Asset Management Inc lifted its stake in Cooper Companies by 4.2% in the fourth quarter. CIBC Asset Management Inc now owns 5,313 shares of the medical device company’s stock worth $1,158,000 after purchasing an additional 212 shares during the last quarter. Edgestream Partners L.P. lifted its stake in Cooper Companies by 26.0% in the third quarter. Edgestream Partners L.P. now owns 1,128 shares of the medical device company’s stock worth $267,000 after purchasing an additional 233 shares during the last quarter. Norinchukin Bank The lifted its stake in Cooper Companies by 7.3% in the third quarter. Norinchukin Bank The now owns 3,638 shares of the medical device company’s stock worth $863,000 after purchasing an additional 248 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System raised its stake in shares of Cooper Companies by 0.3% during the third quarter. State Board of Administration of Florida Retirement System now owns 82,745 shares of the medical device company’s stock valued at $19,620,000 after acquiring an additional 260 shares in the last quarter. 97.45% of the stock is currently owned by institutional investors.
In other Cooper Companies news, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $229.06, for a total transaction of $179,812.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Robert S. Weiss sold 32,500 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $224.70, for a total transaction of $7,302,750.00. Following the completion of the sale, the chief executive officer now owns 119,111 shares in the company, valued at $26,764,241.70. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 54,385 shares of company stock worth $12,289,463. Company insiders own 1.60% of the company’s stock.
Shares of Cooper Companies Inc (COO) traded up $1.30 during midday trading on Wednesday, reaching $241.70. 204,325 shares of the company traded hands, compared to its average volume of 448,453. Cooper Companies Inc has a one year low of $192.24 and a one year high of $256.39. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. The stock has a market cap of $11,593.56, a PE ratio of 31.97, a PEG ratio of 1.90 and a beta of 0.61.
Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating the consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The business had revenue of $561.50 million during the quarter, compared to analysts’ expectations of $558.86 million. During the same quarter in the prior year, the company posted $2.28 EPS. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. research analysts anticipate that Cooper Companies Inc will post 11.6 earnings per share for the current fiscal year.
The business also recently disclosed a semiannual dividend, which was paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd were issued a $0.03 dividend. The ex-dividend date was Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio is currently 0.80%.
ILLEGAL ACTIVITY NOTICE: “UBS Asset Management Americas Inc. Has $121.73 Million Stake in Cooper Companies Inc (COO)” was originally posted by Marea Informative and is owned by of Marea Informative. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.mareainformativa.com/2018/03/15/ubs-asset-management-americas-inc-increases-stake-in-cooper-companies-inc-coo-updated-updated-updated.html.
Cooper Companies Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.